Ethicon Endo-Surgery has announced the approval by FDA for its SEDASYS device. This device is the first computer-assisted personalized sedation (CAPS) system which is a boon to clinicians in the endoscopy suites.
With this system, anesthesiologists and CRNAs can be replaced with computerized technology to administer propofol and to monitor minimal-to-moderate sedation in patients undergoing upper and lower endoscopies.
The company has also added that only ASA class I and II patients can be allowed to receive propofol via SEDASYS.
The company said that the state-of-the-art drug delivery and patient monitoring, the SEDASYS® System can help physician/nurse teams to ensure personalized sedation. Further, the device is capable of detecting and responding to signs of over-sedation by stopping or reducing delivery of propofol, increasing oxygen delivery and automatically instructing patients to take a deep breath.
The SEDASYS® System also keeps track of patients' vital signs like blood pressure, heart rate, oxygen saturation and the degree of patient's response.